Navigation Links
When is a stem cell not really a stem cell?
Date:8/26/2007

Working with embryonic mouse brains, a team of Johns Hopkins scientists seems to have discovered an almost-too-easy way to distinguish between true neural stem cells and similar, but less potent versions. Their finding, reported this week in Nature, could simplify the isolation of stem cells not only from brain but also other body tissues.

What the researchers identified is a specific protein signal that appears to prevent neural stem cells the sort that might be used to rebuild a damaged nervous system from taking their first step toward becoming neurons. Stem cells dont instantly convert into functional adult tissue, says author Nicholas Gaiano, Ph.D., assistant professor at the Institute for Cell Engineering. They undergo a stepwise maturation where they gradually shed their stem cell properties.

The first step turns stem cells into progenitor cells by dictating how signals downstream of a protein called Notch, which regulates stem cells in many different tissues, are transmitted. One well known target of Notch is a protein called CBF1. To help study Notch signaling further, Gaiano and his team created genetically engineered mouse embryos that glow green when CBF1 is turned on.

To their surprise, they noticed that during brain development some of the brain cells generally thought to be neural stem cells stopped glowing, indicating that the CBF1 protein was no longer active in them. A closer look revealed that those cells that went dark were in fact no longer true neural stem cells, which can form all major brain cell types, but instead had aged into progenitor cells, which form mostly neurons.

They tested whether CBF1 was the critical switch by chemically knocking out the protein in neural stem cells. The knockout got the stem cells to rapidly convert to progenitor cells. However, if we activated the CBF1 protein in progenitor cells we couldnt get them to shift back into stem cells, says Gaiano. So whatever happens biochemically once CBF1 is turned off seems to create a one-way street.

Another recent study, using the mouse line generated by the Gaiano group, found that CBF1 signaling may play the same role in blood stem cells, leading Gaiano to suspect that his teams discovery might be a general switch distinguishing stem cells from progenitors in many different tissues.


'/>"/>

Contact: Nick Zagorski
nzagors1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert

Related biology news :

1. Whats really making you sick? Plant pathologists offer the science behind Sick Building Syndrome
2. Researchers seek to discover what really happens when a virus enters the body
3. What does the public really know about HPV?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2016)... 16, 2016 The global wearable medical device market, in ... 2021 from USD 5.31 billion in 2016, at a CAGR of ... ... technological advancements in medical devices, launch of a growing number of ... connectivity among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... 2016  There is much more to innovative access ... engine. Continental will demonstrate the intelligence of today,s solutions ... . Through the combination of the keyless entry and ... elements, the international technology company is opening up new ... "The integration of biometric elements brings our ...
(Date:12/7/2016)... 7, 2016 According to a new market research report ... (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - Global ... from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 18, 2017 Acupath Laboratories, Inc., a leading ... of an Executive Committee that will guide the company,s ... John Cucci , a 15-year veteran of the ... Business Development to Chief Sales Officer .  Prior ... in senior sales leadership roles at several leading lab ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, will feature data ... napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held ... . Napabucasin is an orally-administered investigational ... STAT3. i Cancer stem cells (CSCs) possess the ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January ... NY. The procedure was an anterior cervical discectomy and fusion on a 42 ...
(Date:1/18/2017)... ... January 18, 2017 , ... Researchers from a new study are stating that ... enough after prostate cancer treatment, this indicates there is still remaining prostate cancer cells that ... “ The PSA test has always been an indicator of whether a man’s prostate cancer ...
Breaking Biology Technology: